ID: ALA4451088

Max Phase: Preclinical

Molecular Formula: C32H44O4

Molecular Weight: 492.70

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCOC1=C(C)C2=CC=C3[C@@](C)(CC[C@@]4(C)[C@@H]5C[C@](C)(C(=O)OC)CC[C@]5(C)CC[C@]34C)C2=CC1=O

Standard InChI:  InChI=1S/C32H44O4/c1-9-36-26-20(2)21-10-11-24-30(5,22(21)18-23(26)33)15-17-32(7)25-19-29(4,27(34)35-8)13-12-28(25,3)14-16-31(24,32)6/h10-11,18,25H,9,12-17,19H2,1-8H3/t25-,28-,29-,30+,31-,32+/m1/s1

Standard InChI Key:  RYJSBGHRHFLPHK-JSJVQHDDSA-N

Associated Targets(Human)

Nuclear receptor subfamily 4 group A member 1 458 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HepG2 196354 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 492.70Molecular Weight (Monoisotopic): 492.3240AlogP: 7.26#Rotatable Bonds: 3
Polar Surface Area: 52.60Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 5.95CX LogD: 5.95
Aromatic Rings: 0Heavy Atoms: 36QED Weighted: 0.39Np Likeness Score: 2.76

References

1. Chen Z, Zhang D, Yan S, Hu C, Huang Z, Li Z, Peng S, Li X, Zhu Y, Yu H, Lian B, Kang Q, Li M, Zeng Z, Zhang XK, Su Y..  (2019)  SAR study of celastrol analogs targeting Nur77-mediated inflammatory pathway.,  177  [PMID:31132532] [10.1016/j.ejmech.2019.05.009]

Source